HuveGuard NB Suspension for Oral Suspension for Chickens

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Buy It Now

Active ingredient:

Eimeria brunetti, Eimeria necatrix

Available from:

Huvepharma N.V.

ATC code:

QI01AN01

INN (International Name):

Eimeria brunetti, Eimeria necatrix

Pharmaceutical form:

Suspension for oral suspension

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Chickens

Therapeutic area:

Live Parasitic Vaccine

Authorization status:

Authorized

Authorization date:

2016-08-19

Summary of Product characteristics

                                Revised: September 2020
AN: 02161/2019
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
HuveGuard NB suspension for oral suspension for chickens
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One dose of 0.025 ml contains:
ACTIVE SUBSTANCES:
Sporulated oocysts from two attenuated precocious lines of _Eimeria
_species:
_Eimeria necatrix, _strain mednec
3+8 100 –310 oocysts*
_Eimeria brunetti, _strain roybru 3+28
50 –155 oocysts*
* According to the in vitro counting procedure of the manufacturer at
the time of
blending and at release
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension for oral suspension.
Colourless to white to light beige suspension when shaken.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Chickens
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of chickens to reduce infection and
clinical signs of
coccidiosis caused by _E. necatrix_ and _E. brunetti_.
Onset of immunity: 21 days post vaccination.
Duration of immunity: not demonstrated.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Vaccinate healthy animals only.
The vaccine contains live coccidian oocysts and is dependent upon
replication of the
vaccine strains within the chickens for building up of immunity. It is
common to find
oocysts in the gastro-intestinal tract of vaccinated birds from 1–3
weeks or more after
Revised: September 2020
AN: 02161/2019
Page 2 of 6
vaccination. These oocysts are most likely to be vaccinal oocysts
which recycle in the
birds via the litter. Recycling of oocysts is necessary for the
development of immunity
and for continued protection.
Since the protection against coccidial infection following vaccination
is enhanced by
natural challenge, access to any therapeutic agents having
anti-coccidial activity at
any time following vaccination can adversely affect the development of
immunity.
This is important throughout the life of the chicken.
4.5
SPECIAL PRECAUTIONS FOR USE
S
                                
                                Read the complete document